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Objective: To compare muscle strength (i.e. lower- and upper-body strength) and function
between physically inactive childhood-onset systemic lupus erythematosus patients (C-SLE)
and healthy controls (CTRL).
Methods: This was a cross-sectional study and the sample consisted of 19 C-SLE (age between
9  and 18 years) and 15 CTRL matched by age, sex, body mass index (BMI), and physical
activity levels (assessed by accelerometry). Lower- and upper-body strength was assessed
by  the one-repetition-maximum (1-RM) test. Isometric strength was assessed through a
handgrip dynamometer. Muscle function was evaluated by the timed-stands test (TST) and
the  timed-up-and-go test (TUG).
Results: When compared with CTRL, C-SLE showed lower leg-press and bench-press 1-
RM  (p = 0.026 and p = 0.008, respectively), and a tendency toward lower handgrip strength
(p  = 0.052). C-SLE showed lower TST scores (p = 0.036) and a tendency toward higher TUG
scores  (p = 0.070) when compared with CTRL.
Conclusion: Physically inactive C-SLE patients with very mild disease showed reduced mus-
cle  strength and functionality when compared with healthy controls matched by physical
activity levels. These ﬁndings suggest C-SLE patients may greatly suffer from a physically
inactive lifestyle than healthy controls do. Moreover, some sub-clinical “residual” effect of
the  disease or its pharmacological treatment seems to affect C-SLE patients even with awell-controlled disease.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-NDlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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255-5021/© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Reduc¸ão  na  forc¸a  muscular  e  capacidade  funcional  em  pacientes
ﬁsicamente  inativos  com  lúpus  eritematoso  sistêmico  de  início  juvenil,
apesar  de  doenc¸a muito  leve
Palavras-chave:
Forc¸a muscular
Capacidade funcional
Doenc¸a reumática
Nível de atividade física
r  e  s  u  m  o
Objetivo: Comparar a forc¸a  muscular (ou seja, a forc¸a muscular dos membros inferiores e
superiores) e a capacidade funcional de pacientes ﬁsicamente inativos com lúpus eritem-
atoso  sistêmico de início juvenil LESJ com controles saudáveis (CTRL).
Métodos: Trata-se de um estudo transversal cuja amostra foi composta por 19 pacientes
com  LESJ (idades entre 9 a 18 anos) e 15 CTRL pareados por idade, sexo, índice de massa
corporal (IMC) e nível de atividade física (avaliada através do uso de acelerômetros). A forc¸a
de  membros inferiores e superiores foi avaliada pelo teste de uma repetic¸ão máxima (1-
RM). A forc¸a isométrica foi avaliada com o uso de um dinamômetro. A capacidade funcional
foi  avaliada pelo Timed-stands test (TST) e Timed-up-and-go test (TUG).
Resultados: Quando comparados aos CTRL, os pacientes com LESJ apresentaram menor forc¸a
em  1-RM no leg press e supino (p = 0,026 e p = 0,008, respectivamente), e uma tendência a
menor forc¸a de preensão manual (p = 0,052). Os pacientes com LESJ apresentaram menores
escores no TST (p = 0,036) e uma tendência a maior tempo de execuc¸ão no TUG (p = 0,070),
quando comparados ao grupo CTRL.
Conclusão: Pacientes com LESJ, ﬁsicamente inativos, com doenc¸a muito leve mostraram
reduc¸ão  na forc¸a muscular e capacidade funcional quando comparados a controles
saudáveis pareados por níveis de atividade física. Estes achados sugerem que pacientes
com LESJ podem apresentar mais efeitos deletérios por manter um estilo de vida ﬁsica-
mente inativo do que controles saudáveis. Além disso, alguns efeitos “residuais” subclínicos
da  doenc¸a ou o tratamento farmacológico parecem afetar pacientes com LESJ, mesmo com
uma  doenc¸a bem controlada.
© 2016 Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CCIntroduction
Childhood-onset systemic lupus erythematosus (C-SLE) is an
autoimmune disease characterized by B and T cells hyper-
activity, formation and deposition of antibodies throughout
the body, which results in chronic systemic inﬂammation and
multi-organ involvement (e.g. skin, kidney, muscle, cardiovas-
cular system, etc.).1–4 C-SLE has a prevalence of 3–24 cases
per 100,000 inhabitants5 and has been associated with a more
severe disease than adult-SLE.6
Disease itself (e.g. systemic inﬂammation) and drug reg-
imen (e.g. prolonged corticoid use) may contribute to a
multitude of clinical manifestations (e.g. musculoskeletal
disorders, physical dysfunction and fatigue),7–9 which may,
ultimately, predispose patients to a sedentary lifestyle. A
sedentary lifestyle, in turn, may negatively affect physi-
cal capacity, function, and health-related quality of life,
in a vicious circle of physical inactivity and poor clini-
cal outcomes.10 A few studies have shown that pediatric
rheumatic populations are not engaged in sufﬁcient lev-
els of physical activity compared to healthy children and
adolescents.11–13 However, although it is plausible to assume
that a sedentary behavior may affect physical capacity, this
remains to be determined.The aim of this study was to compare muscle strength
(i.e. lower- and upper-body strength) and function between
physically inactive C-SLE and healthy controls (CTRL). WeBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
hypothesized that physically inactive patients with low dis-
ease activity and low cumulative damage would show similar
muscle strength and function when compared to healthy con-
trols matched for physical activity levels.
Patients  and  methods
Study  design  and  patients
This was a cross-sectional study conducted in Sao Paulo, Brazil
(Clinical Hospital, School of Medicine, University of Sao Paulo).
The sample consisted of 19 C-SLE patients (age between 9
and 18 years) and 15 healthy controls (CTRL) matched for
age, sex, body mass index (BMI), and physical activity levels
(assessed by accelerometer). Aerobic capacity, health-related
quality of life, and physical activity level data from part of
this sample has been reported elsewhere.14 Disease activity
was determined by means of Systemic Lupus Erythematosus
Disease Activity Index 2000 (SLEDAI) scores,15 and cumula-
tive damage by Systemic Lupus International Collaborating
Clinics/ACR Damage Index (SLICC) scores.16 All patients ful-
ﬁlled the revised American College of Rheumatology criteria
for the diagnosis of C-SLE.17 Healthy subjects, recruited by
local advertising at University of Sao Paulo, were free of any
current or past chronic diseases, and were not engaged in any
exercise training programs.
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Exclusion criteria were as follows: (1) physically
ctive patients (according to general physical activity
ecommendations)18; (2) cardiovascular and musculoskeletal
isorders; (3) kidney and pulmonary involvement; (4) periph-
ral neuropathy, (5) secondary rheumatic disease (e.g. Sjögren
yndrome, ﬁbromyalgia, and antiphospholipid syndrome).
The Committee of Ethics in Research of the General Hos-
ital of the School of Medicine, University of Sao Paulo, Brazil
CAPPesq) approved the study and all legal guardians provided
ritten informed consent.
hysical  activity  level  assessment
hysical activity was objectively measured using Actigraph
T3X® accelerometers (ActiGraph, Pensacola, FL). All partic-
pants were instructed to wear the accelerometer during
aking hours, except when bathing or swimming, for seven
onsecutive days. All participants accumulated at least ten
ours of valid activity recordings per day for at least ﬁve
ays. Data were exported from the device in 15-s epochs
or children and adolescents, using ActiLife 6 software (Acti-
raph, Pensacola, FL). Everson cut-points were used to deﬁne
pochs for children and adolescents as follows: sedentary time
<100 counts/min), light-intensity physical activity (≥101 to
2295 counts/min), and MVPA  (moderate-to-vigorous physical
ctivity) (≥2296 counts/min).19 Physical activity guidelines rec-
mmend a minimum of 60 min/day of MVPA  for children and
dolescents.18 Thus, participants were considered physically
ctive if they met  this recommendation.
uscle  strength  and  function
articipants performed two preliminary sessions, separated by
t least 72 hours, to familiarize themselves to the main exer-
ise tests. These consisted of one-repetition-maximum (1-RM)
ests to determine both upper- and lower-body muscular
trength, as assessed by bench-press and leg-press exercise,
espectively. Prior to the 1-RM test, two light warm-up sets
nterspersed by two-minute intervals were performed. Subse-
uently, participants achieved 1-RM for each exercise in 1–5
ttempts interspersed by 3-min intervals.20 1-RM tests were
onducted by two experienced researchers and verbal encour-
gement was provided during testing sessions.
Isometric strength was assessed through a handgrip
ynamometer (Takei A5001 Hand Grip Dynamometer, Takei
cientiﬁc Instruments Co., Ltd., Tokyo, Japan). The protocol
onsisted of three maximal isometric contractions of 5 s inter-
persed with 60-s recovery periods. The test was performed on
he participant’s dominant hand.21
Muscle function was evaluated by the timed-stands test
TST) and the timed-up-and-go test (TUG). TST assesses the
aximum number of stand-ups that a subject can perform
rom a standard armless chair within 30 s,22 whereas TUG
ssesses the time required for the subject to rise from a
tandard arm chair, walk toward a 3-meters line drawn on the
oor, turn, return to the chair, and sit down again.23tatistical  analysis
ata normality was tested using the Shapiro–Wilk W-
est. Independent samples were compared using either the 6;5 6(6):509–514 511
unpaired T-test for normally distributed variables or the
Mann–Whitney U-test for non-normally distributed variables.
Data analysis was performed using the SPSS (17.0) for Win-
dows. The level of signiﬁcance was set at p ≤ 0.05. Data are
presented as mean ± standard deviation (SD), 95% conﬁdence
interval of the difference (CI) were also calculated.
Results
Table 1 shows demographic data, current clinical treatment,
disease activity and damage parameters in C-SLE and CTRL.
Groups were comparable regarding age, sex, BMI  and physical
activity levels (p > 0.05).
Muscle  strength  and  function
Muscle strength and function data are presented in Table 2.
When compared with CTRL, C-SLE showed lower leg-press and
bench-press 1-RM (p = 0.026 and p = 0.008, respectively), and a
tendency toward lower handgrip strength (p = 0.052).
Additionally, C-SLE showed lower TST scores (p = 0.036) and
a tendency toward higher TUG scores (p = 0.070) when com-
pared with CTRL.
Discussion
The main ﬁnding of this study was that physically inactive C-
SLE patients with very mild and well-controlled disease had
impaired muscle strength and function when compared with
healthy controls matched by physical activity levels.
Disease-related symptoms and clinical manifestations
may predispose the pediatric rheumatic patient to a physically
inactive lifestyle.10,24,25 Physical inactivity in childhood may
track into adulthood and senescence, and has been associated
with a higher risk of developing chronic diseases (e.g. obesity,
type 2 diabetes, hypertension), and all-cause mortality.26–28
Moreover, physical inactivity may result in weakness and
muscle dysfunction, ultimately leading to poor health-related
quality of life.10,26 In this study, we expected that C-SLE
patients with very mild disease (i.e. low cumulative damage
and low disease activity) would show similar levels of muscle
strength and function when compared with controls matched
by physical inactivity. Based on our ﬁndings, nonetheless,
one may assume that insufﬁcient physical activity level may
impose a greater “cost” to C-SLE than to healthy controls in
relation to weakness and muscle dysfunction.
It is not clear why muscle strength and function highly
differ physically inactive well-controlled C-SLE patients and
healthy controls. To avoid any apparent disease-related symp-
toms that could potentially account for differences in physical
capacity, we  selected only patients with low disease activity
(mean SLEDAI = 2), low cumulative damage (mean SLICC = 0.4),
and free of musculoskeletal involvement. Yet, remarkable
differences in muscle strength and function were noted, sug-
gesting that other factors may have adversely affected C-SLE.
Drug regimen is one of the potential factor to explain these
ﬁndings. Long-term corticoid therapy, for instance, has been
associated with many  adverse effects and damages in pedi-
atric populations (e.g. growth suppression, weight gain, bone
mass loss, myopathy, ocular complications),6,7,9,29 which may
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Table 1 – Demographic, current clinical and treatment data in C-SLE and CTRL.
C-SLE
(n = 19)
CTRL
(n  = 15)
p
Age (years) 14.5 ± 2.5 14.7 ± 4.0 0.901
Weight (kg) 52.4 ± 17.2 56.4 ± 19.3 0.532
Height (cm) 154.8 ± 0.2 161.4 ± 0.2 0.221
BMI (kg/m2) 21.4 ± 4.3 21.0 ± 4.1 0.777
Disease parameters
SLEDAI 2.3 ± 2.2 – –
SLICC 0.4 ± 0.6 – –
Disease duration (years) 3.5  ± 2.7 – –
Drugs
Current use of prednisone (mg/kg) 5.4 ± 7.6 – –
Cumulative use of prednisone (g/kg) 13.6 ± 8.0 – –
Hydroxychloroquine [n◦(%)] 16 (84.2%) – –
Metotrexate [n◦(%)] 3 (15.8%) – –
Azathioprine [n◦(%)] 9 (47.4%) – –
Physical activity level
Sedentary time (min/day) 592.3 ± 72.4 566.9 ± 92.1 0.375
Light PA (min/day) 230.8 ± 63.2 256.2 ± 68.8 0.271
MVPA (min/day) 36.3 ± 16.1 30.0 ± 15.6 0.258
BMI, body mass index; MVPA, moderate-to-vigorous; PA, physical activity; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLICC,
Systemic Lupus International Collaborating Clinics/ACR Damage Index.
Data are expressed as means ± SD.
Table 2 – Muscle strength and function in C-SLE and CTRL groups.
C-SLE
(n = 19)
CTRL
(n  = 15)
p  95% CI
Lower Upper
Leg press (kg) 96.9 ± 39.3 135.9 ± 50.9 0.026a −72.93 −4.99
Bench press (kg) 17.7 ± 5.7 24.6 ± 8.3 0.008a −11.85 −1.93
Hand grip (kg) 21.3 ± 6.7 26.0 ± 6.3 0.052 −9.36 0.04
Timed stands test (reps) 18.1 ± 1.6 19.6 ± 2.2 0.036a −2.83 −0.11
Timed up & go test (s) 5.5 ± 0.5 5.2 ± 0.3 0.070 −0.04 0.62
Data are expressed as means ± SD.
CI, conﬁdence intervals.
.a Signiﬁcant difference when compared to healthy control groups
explain, at least partially, the reduction in physical capac-
ity experienced by C-SLE patients. Moreover, studies have
shown that C-SLE patients may have selective atrophy of type-
II muscle ﬁber, impaired excitation–contraction coupling, and
microcirculatory lesions,30,31 which could directly affect mus-
cle strength and function in this disease. The inﬂuence of
potential abnormal muscle morphology upon muscle dysfunc-
tion in C-SLE remains unclear, as we were unable to measure
muscle mass or any other muscle physiological parameters in
this study.
Adult-SLE populations appear to have reduced physical
capacity (e.g. aerobic conditioning, muscle strength and
function), higher fatigue and disability when compared with
their health counterparts.32–34 To the best of our knowledge,
only one study showed lower aerobic capacity, higher fatigue,
35and poorer health-related quality of life in a C-SLE cohort,
although physical activity level was not well-controlled in
this investigation. From our ﬁndings, it is possible to infer
that physical inactivity can contribute to aggravate musclefunction deﬁcits seen in C-SLE patients to a greater extent
than in healthy controls. Further studies involving only phys-
ically active patients and controls may provide novel insights
on the impact of a broader range of physical activity levels
on strength and function, allowing testing whether increased
physical activity may overcome muscle dysfunction in C-SLE.
Increased activity levels through exercise training pro-
grams have been proven to be effective on counteracting
disease-related symptoms and improve physical capacity in
several rheumatic populations.10,25,36–38 To the best of our
knowledge, however, a single case report and a single ran-
domized controlled trial have been conducted to test the
efﬁcacy of aerobic training in C-SLE patients,36,39 with both of
them showing positive ﬁndings in relation to improvements
in physical capacity, disease symptoms, and health-related
quality of life. Further studies are clearly necessary to inves-
tigate the efﬁcacy and safety of more  complex interventions
in C-SLE (e.g. structured and non-structured activities aimed
at improving both aerobic and muscle function, enjoyable
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hildren-oriented physical activities, programs focused on
educing sedentary time, individual and collective sports).
In conclusion, physically inactive C-SLE patients with very
ild disease showed reduced muscle strength and functional-
ty when compared with healthy controls matched by physical
ctivity levels. These ﬁndings suggest C-SLE patients may
reatly suffer from a physically inactive lifestyle than healthy
ontrols do. Moreover, some sub-clinical “residual” effect of
he disease or its pharmacological treatment seems to affect
-SLE patients even with a well-controlled disease.
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